The global autologous cell therapy market size is calculated at USD 11.43 billion in 2025 and is forecasted to reach around USD 53.73 billion by 2034, accelerating at a CAGR of 18.86% from 2025 to 2034. The North America autologous cell therapy market size surpassed USD 4.20 billion in 2024 and is expanding at a CAGR of 18.90% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Autologous Cell Therapy Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Autologous Cell Therapy Market Revenue and Volume, by Source
8.1.1 Epidermis
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Bone Marrow
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Mesenchymal Stem Cells
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. Haematopoietic Stem Cells
8.1.4.1. Market Revenue and Volume Forecast
8.1.5. Chondrocytes
8.1.5.1. Market Revenue and Volume Forecast
8.1.6. Others
8.1.6.1. Market Revenue and Volume Forecast
9.1. Autologous Cell Therapy Market Revenue and Volume, by Application
9.1.1. Cancer
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Cardiovascular Disorders
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Neurodegenerative Disorders
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. Autoimmune Disorders
9.1.4.1. Market Revenue and Volume Forecast
9.1.5. Orthopedics
9.1.5.1. Market Revenue and Volume Forecast
9.1.6. Wound Healing
9.1.6.1. Market Revenue and Volume Forecast
9.1.7. Others
9.1.7.1. Market Revenue and Volume Forecast
10.1. Autologous Cell Therapy Market Revenue and Volume, by End-Use
10.1.1. Hospitals & Clinics
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Ambulatory Centers
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Academics & Research
10.1.3.1. Market Revenue and Volume Forecast
10.1.4. Others
10.1.4.1. Market Revenue and Volume Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Source
11.1.2. Market Revenue and Volume Forecast, by Application
11.1.3. Market Revenue and Volume Forecast, by End-Use
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Source
11.1.4.2. Market Revenue and Volume Forecast, by Application
11.1.4.3. Market Revenue and Volume Forecast, by End-Use
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Source
11.1.5.2. Market Revenue and Volume Forecast, by Application
11.1.5.3. Market Revenue and Volume Forecast, by End-Use
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Source
11.2.2. Market Revenue and Volume Forecast, by Application
11.2.3. Market Revenue and Volume Forecast, by End-Use
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Source
11.2.4.2. Market Revenue and Volume Forecast, by Application
11.2.4.3. Market Revenue and Volume Forecast, by End-Use
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Source
11.2.5.2. Market Revenue and Volume Forecast, by Application
11.2.5.3. Market Revenue and Volume Forecast, by End-Use
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Source
11.2.6.2. Market Revenue and Volume Forecast, by Application
11.2.6.3. Market Revenue and Volume Forecast, by End-Use
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Source
11.2.7.2. Market Revenue and Volume Forecast, by Application
11.2.7.3. Market Revenue and Volume Forecast, by End-Use
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Source
11.3.2. Market Revenue and Volume Forecast, by Application
11.3.3. Market Revenue and Volume Forecast, by End-Use
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Source
11.3.4.2. Market Revenue and Volume Forecast, by Application
11.3.4.3. Market Revenue and Volume Forecast, by End-Use
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Source
11.3.5.2. Market Revenue and Volume Forecast, by Application
11.3.5.3. Market Revenue and Volume Forecast, by End-Use
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Source
11.3.6.2. Market Revenue and Volume Forecast, by Application
11.3.6.3. Market Revenue and Volume Forecast, by End-Use
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Source
11.3.7.2. Market Revenue and Volume Forecast, by Application
11.3.7.3. Market Revenue and Volume Forecast, by End-Use
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Source
11.4.2. Market Revenue and Volume Forecast, by Application
11.4.3. Market Revenue and Volume Forecast, by End-Use
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Source
11.4.4.2. Market Revenue and Volume Forecast, by Application
11.4.4.3. Market Revenue and Volume Forecast, by End-Use
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Source
11.4.5.2. Market Revenue and Volume Forecast, by Application
11.4.5.3. Market Revenue and Volume Forecast, by End-Use
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Source
11.4.6.2. Market Revenue and Volume Forecast, by Application
11.4.6.3. Market Revenue and Volume Forecast, by End-Use
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Source
11.4.7.2. Market Revenue and Volume Forecast, by Application
11.4.7.3. Market Revenue and Volume Forecast, by End-Use
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Source
11.5.2. Market Revenue and Volume Forecast, by Application
11.5.3. Market Revenue and Volume Forecast, by End-Use
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Source
11.5.4.2. Market Revenue and Volume Forecast, by Application
11.5.4.3. Market Revenue and Volume Forecast, by End-Use
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Source
11.5.5.2. Market Revenue and Volume Forecast, by Application
11.5.5.3. Market Revenue and Volume Forecast, by End-Use
12.1. Autolus Therapeutics
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Lineage Cell Therapeutics, Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Sangamo Therapeutics
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Holostem Terapie Avanzate S.r.l.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Vericel Corporation
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Opexa Therapeutics
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. BrainStorm Cell Therapeutics
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Pharmicell Co., Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Bayer AG
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Daiichi Sankyo Co., Ltd
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample